Seroprevalence, distribution, and risk factors for human leptospirosis in the United States Virgin Islands.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
01
08
2022
accepted:
10
10
2022
entrez:
15
11
2022
pubmed:
16
11
2022
medline:
19
11
2022
Statut:
epublish
Résumé
The first documented human leptospirosis cases in the U.S. Virgin Islands (USVI) occurred following 2017 Hurricanes Irma and Maria. We conducted a representative serosurvey in USVI to estimate the seroprevalence and distribution of human leptospirosis and evaluate local risk factors associated with seropositivity. A stratified, two-stage cluster sampling design was used and consisted of three island strata and random selection of census blocks and then households. All eligible members of selected households were invited to participate (≥5 years old, resided in USVI ≥6 months and ≥6 months/year). Household and individual-level questionnaires were completed, and serum collected from each enrolled individual. Microscopic agglutination test serology was conducted, and bivariate and logistic regression analyses completed to identify risk factors for seropositivity. In March 2019, 1,161 individuals were enrolled from 918 households in St. Croix, St. Thomas, and St. John. The territory-wide weighted seroprevalence was 4.0% (95% CI:2.3-5.7). Characteristics/exposures independently associated with seropositivity using logistic regression included contact with cows (OR: 39.5; 95% CI: 9.0-172.7), seeing rodents/rodent evidence or contact with rodents (OR: 2.6; 95% CI: 1.1-5.9), and increasing age (OR: 1.02; 95% CI: 1.002-1.04); full or partial Caucasian/White race was negatively correlated with seropositivity (OR: 0.02, 95% CI: 0.04-0.7). Bivariate analysis showed self-reported jaundice since the 2017 hurricanes (pRR: 5.7; 95% CI: 1.0-33.4) was associated with seropositivity and using a cover/lid on cisterns/rainwater collection containers (pRR: 0.3; 95% CI: 0.08-0.8) was protective against seropositivity. Leptospirosis seropositivity of 4% across USVI demonstrates an important human disease that was previously unrecognized and emphasizes the importance of continued leptospirosis surveillance and investigation. Local risk factors identified may help guide future human and animal leptospirosis studies in USVI, strengthen leptospirosis public health surveillance and treatment timeliness, and inform targeted education, prevention, and control efforts.
Sections du résumé
BACKGROUND
The first documented human leptospirosis cases in the U.S. Virgin Islands (USVI) occurred following 2017 Hurricanes Irma and Maria. We conducted a representative serosurvey in USVI to estimate the seroprevalence and distribution of human leptospirosis and evaluate local risk factors associated with seropositivity.
METHODOLOGY/PRINCIPAL FINDINGS
A stratified, two-stage cluster sampling design was used and consisted of three island strata and random selection of census blocks and then households. All eligible members of selected households were invited to participate (≥5 years old, resided in USVI ≥6 months and ≥6 months/year). Household and individual-level questionnaires were completed, and serum collected from each enrolled individual. Microscopic agglutination test serology was conducted, and bivariate and logistic regression analyses completed to identify risk factors for seropositivity. In March 2019, 1,161 individuals were enrolled from 918 households in St. Croix, St. Thomas, and St. John. The territory-wide weighted seroprevalence was 4.0% (95% CI:2.3-5.7). Characteristics/exposures independently associated with seropositivity using logistic regression included contact with cows (OR: 39.5; 95% CI: 9.0-172.7), seeing rodents/rodent evidence or contact with rodents (OR: 2.6; 95% CI: 1.1-5.9), and increasing age (OR: 1.02; 95% CI: 1.002-1.04); full or partial Caucasian/White race was negatively correlated with seropositivity (OR: 0.02, 95% CI: 0.04-0.7). Bivariate analysis showed self-reported jaundice since the 2017 hurricanes (pRR: 5.7; 95% CI: 1.0-33.4) was associated with seropositivity and using a cover/lid on cisterns/rainwater collection containers (pRR: 0.3; 95% CI: 0.08-0.8) was protective against seropositivity.
CONCLUSIONS/SIGNIFICANCE
Leptospirosis seropositivity of 4% across USVI demonstrates an important human disease that was previously unrecognized and emphasizes the importance of continued leptospirosis surveillance and investigation. Local risk factors identified may help guide future human and animal leptospirosis studies in USVI, strengthen leptospirosis public health surveillance and treatment timeliness, and inform targeted education, prevention, and control efforts.
Identifiants
pubmed: 36378681
doi: 10.1371/journal.pntd.0010880
pii: PNTD-D-22-00709
pmc: PMC9665390
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010880Informations de copyright
Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Ann N Y Acad Sci. 1992 Jun 16;653:168-71
pubmed: 1626866
Am J Trop Med Hyg. 2009 Oct;81(4):695-7
pubmed: 19815889
J Wildl Dis. 2018 Jul;54(3):450-459
pubmed: 29715063
Am J Trop Med Hyg. 2017 Oct;97(4):1085-1087
pubmed: 28722594
Epidemiol Infect. 1989 Aug;103(1):143-56
pubmed: 2789146
J Gen Microbiol. 1985 Feb;131(2):377-85
pubmed: 3981131
PLoS One. 2019 May 29;14(5):e0217643
pubmed: 31141558
Nat Rev Microbiol. 2017 May;15(5):297-307
pubmed: 28260786
Curr Top Microbiol Immunol. 2015;387:65-97
pubmed: 25388133
N Z Med J. 1984 Feb 8;97(749):83-6
pubmed: 6583569
Emerg Infect Dis. 2011 Feb;17(2):221-6
pubmed: 21291592
Eur J Epidemiol. 2001;17(7):601-8
pubmed: 12086073
Trans R Soc Trop Med Hyg. 1979;73(5):591-3
pubmed: 531914
Emerg Infect Dis. 2012 Jan;18(1):91-4
pubmed: 22257492
Trop Doct. 2010 Apr;40(2):92-4
pubmed: 20305103
Curr Top Microbiol Immunol. 2015;387:99-137
pubmed: 25388134
Int J Zoonoses. 1982 Jun;9(1):51-6
pubmed: 7174234
Trans R Soc Trop Med Hyg. 2010 Oct;104(10):631-8
pubmed: 20813388
Lancet. 1999 Sep 4;354(9181):820-5
pubmed: 10485724
Trop Med Infect Dis. 2021 May 24;6(2):
pubmed: 34073665
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008264
pubmed: 22336839
J Environ Public Health. 2019 Jul 11;2019:1760950
pubmed: 31379953
Clin Microbiol Rev. 2001 Apr;14(2):296-326
pubmed: 11292640
PLoS One. 2020 Jan 27;15(1):e0227055
pubmed: 31986154
Lancet Infect Dis. 2003 Dec;3(12):757-71
pubmed: 14652202
Am J Trop Med Hyg. 1999 Sep;61(3):399-404
pubmed: 10497979
PLoS Negl Trop Dis. 2022 Jun 13;16(6):e0010506
pubmed: 35696427
Am J Trop Med Hyg. 1993 Jan;48(1):35-43
pubmed: 8427386
Ann Intern Med. 1984 May;100(5):696-8
pubmed: 6712032
PLoS Negl Trop Dis. 2016 Oct 11;10(10):e0005025
pubmed: 27727271
Sci Rep. 2022 Jan 21;12(1):1132
pubmed: 35064157
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009154
pubmed: 33657101
Pathog Glob Health. 2013 Sep;107(6):329-34
pubmed: 24188242
Zoonoses Res. 1963 Dec;2:152-227
pubmed: 14170551
Am J Trop Med Hyg. 2018 Oct;99(4):849-851
pubmed: 30141390
PLoS Negl Trop Dis. 2015 Sep 17;9(9):e0003898
pubmed: 26379143
Am J Trop Med Hyg. 2002 Jan;66(1):61-70
pubmed: 12135270
Trop Med Int Health. 2003 Jul;8(7):639-42
pubmed: 12828547
Res Rep Trop Med. 2016 Sep 28;7:49-62
pubmed: 30050339
Rev Panam Salud Publica. 2020 Jul 15;44:e78
pubmed: 32684917
PLoS Negl Trop Dis. 2008 Apr 23;2(4):e228
pubmed: 18431445
Open Forum Infect Dis. 2019 Jun 05;6(7):ofz261
pubmed: 31289729
Rev Panam Salud Publica. 2017 Dec 19;41:e166
pubmed: 31384278
Rev Panam Salud Publica. 2011 May;29(5):350-7
pubmed: 21709940
Curr Opin Infect Dis. 2005 Oct;18(5):376-86
pubmed: 16148523
Am J Trop Med Hyg. 2014 Sep;91(3):642-4
pubmed: 24914001
Am J Trop Med Hyg. 2011 Aug;85(2):275-81
pubmed: 21813847
PLoS Negl Trop Dis. 2021 Nov 15;15(11):e0009859
pubmed: 34780473
Acta Trop. 2005 Oct;96(1):36-46
pubmed: 16083836
PLoS One. 2012;7(7):e39672
pubmed: 22808049
Ann Trop Med Parasitol. 1990 Jun;84(3):255-66
pubmed: 2222028
Clin Infect Dis. 2003 Feb 15;36(4):447-52
pubmed: 12567302